4.7 Article

Persicaria hydropiper (L.) Spach and its Flavonoid Components, Isoquercitrin and Isorhamnetin, Activate the Wnt/β-catenin Pathway and Inhibit Adipocyte Differentiation of 3T3-L1 Cells

期刊

PHYTOTHERAPY RESEARCH
卷 25, 期 11, 页码 1629-1635

出版社

WILEY
DOI: 10.1002/ptr.3469

关键词

flavonoid; 3T3-L1 preadipocyte; isoquercitrin; Wnt/beta-catenin pathway

资金

  1. National Research Foundation (NRF)
  2. Ministry of Education, Science and Technology of Korea government (MEST) (Translational Research Center for Protein Function Control) [2010-0001919, 2010-0026844]
  3. Enprani Co
  4. Incheon
  5. Ministry of Knowledge Economy (through the Korea Research Institute of Chemical Technology) [SI-095]
  6. National Research Foundation of Korea [2010-0026844] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Obesity, which is related to metabolic syndrome and is associated with liver disease, represents an epidemic problem demanding effective therapeutic strategies. Evidence shows that the Wnt/beta-catenin pathway is closely associated with obesity and that small molecules regulating the Wnt/beta-catenin pathway can potentially control adipogenesis related to obesity. Eleven plant extracts activating the Wnt/beta-catenin pathway were screened by using HEK 293-TOP cells retaining the Wnt/beta-catenin signaling reporter gene. An extract of Persicaria hydropiper ( L.) Spach was found to activate Wnt/beta-catenin signaling. P. hydropiper is grown worldwide in temperate climates and is found widely in Southeast Asia. The P. hydropiper extract inhibited the differentiation of adipocyte 3T3-L1 cells. Isoquercitrin and isorhamnetin, constituents of P. hydropiper, also activated Wnt/beta-catenin signaling and suppressed the differentiation of 3T3-L1 cells. These results indicate that isoquercitrin in P. hydropiper suppresses the adipogenesis of 3T3-L1 cells via the inhibition of Wnt/beta-catenin signaling. P. hydropiper and isoquercitrin may therefore be potential therapeutic agents for obesity and its associated disorders. Copyright (C) 2011 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据